For the detection of the breast cancer biomarker HER2, the researchers developed a light-responsive DNA origami structure, which incorporated a protein coating with targeted function on its surface and added a serum albumin camouflage agent to protect the DNA nanostructures. Here, ERBB2 is linked to breast carcinoma.